BREAKING: FDA Chief Responds to Report Saying He ‘Slow-Walked’ Abortion Pill Safety Review

Food and Drug Administration Commissioner Dr. Marty Makary said the review of the abortion drug mifepristone is in the “data acquisition phase” following a report saying he is delaying the process.

“We do an ongoing review, but we’re also engaging in a robust study that can serve to validate or not validate other numbers that have been put out there in the literature,” he told The Daily Signal in an exclusive interview.